Skip to main content
. 2017 May 6;8(43):75350–75360. doi: 10.18632/oncotarget.17642

Table 2. Quality assessment of included studies based on the Quality In Prognosis Studies (QUIPS).

Study Quality evaluation of prognosis study Total scorea Level of evidenceb
Study participation Study attrition Prognostic factor measurement Outcome measurement Study confounding Statistical analysis and reporting
Hao 2016 [14] Yes Yes Yes Partly Partly Yes 6 2b
Ali 2016 [15] Yes Yes Partly Partly Partly Yes 6 2b
Wang 2015 [4] Yes Yes Yes Yes Partly Yes 7 1b
Lim 2015 [16] Yes Yes Yes Partly Partly Yes 8 1b
Kalniete 2015 [17] Yes Yes Yes Partly Partly Yes 7 1b
Chen 2014 [18] Yes Yes Yes Yes Partly Yes 7 1b
Wang 2014 [19] Yes Yes Yes Yes Partly Yes 7 1b
Wang (a)2013 [20] Yes Yes Yes Yes Partly Yes 8 1b
Wang (b) 2013 [21] Yes Yes Yes Partly Partly Yes 7 2b
Zhou 2013 [22] Yes Yes Partly Partly Partly Yes 5 2b
Xia 2012 [23] Yes Yes Partly Partly Partly Yes 6 2b
Marchini 2011 [24] Yes Yes Yes Yes Partly Yes 8 1b
Ueda 2010 [25] Yes Yes Yes Yes Partly Yes 8 1b

a Quality assessment of included studies based on the Newcastle–Ottawa Scale.

b The levels of evidence were estimated for all included studies with the Oxford Centre for Evidence Based Medicine criteria.